Select Issue Date:
- Fall 2013
- Summer 2013
- Spring 2013
- Winter 2013
- Fall 2012
- Summer 2012
- Spring 2012
- MGH Research Issue
- Summer 2011
- Spring 2011
- Winter 2011
- Fall 2010
- Summer 2010
- Spring 2010
- Winter 2010
- Fall 2009
- Summer 2009
- Spring 2009
- Winter 2009
- Fall 2008
- Summer 2008
- Spring 2008
- Winter 2008
- Fall 2007
- Summer 2007
- Spring 2007
- Winter 2007
- Fall 2006
- Summer 2006
- Spring 2006
- Winter 2006
- Fall 2005
Statins’ ability to control cholesterol is undeniable. Less certain, after almost 25 years, is whether benefits outweigh potential harm.
Melanoma, almost impossible to treat after it metastasizes, appears vulnerable to two new approaches that could someday be combined.
Scientists are uncovering thousands of metabolites, all of which provide unique evidence of bodily functions and dysfunctions.
Employing ingenuity, technology and an artist’s eye, scientists interpret and elucidate the brain’s stunning complexity.
The far-flung tumors of tuberous sclerosis complex, noncancerous but hardly benign, are shedding light on how malignancies develop.
In honor of Massachusetts General Hospital’s bicentennial, Peter L. Slavin and David F. Torchiana reflect on how Proto might have looked 200 years ago.
Proto readers question the necessity of gene patents and discuss a return to psychedelic research.
Scientists say they've confirmed the bacteria behind the pestilence that killed millions in Europe in the Middle Ages.
Douglas Farrago’s bimonthly collection of top-ten lists, editorials and “True Stories of Medicine” provides a sharp satire of the health care system.
Treating delirious patients can be costly and difficult, where hospitalization itself may exacerbate the disorder.
From lead to mercury to trichloromethane, we're awash in chemicals, but researchers are still trying understand how our exposure affects us.
The city’s first hospital was founded to treat the poor—and serve as a teaching locale for Harvard Medical School.
Medical bloggers discuss how smartphones and iPads will change the way they practice medicine.
With the aid of the internet and supercomputers, a virtual version of this procedure may reduce incidences of colorectal cancer.
New AIDS research and the study of asymptomatic HIV-positive patients, has brought optimism to those looking to cure the disease.
Trials that involve new drugs being compared to existing versions could let inferior treatments slip through.
When a doctor becomes addicted, colleagues may not be equipped to spot or treat it.